Negocios · 17/11/19971 min de lectura
European Research Associates, Ltd. et al.; Withdrawal of Approval of Three New Drug Applications
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is withdrawing approval of three new drug applications (NDA's). The basis for the withdrawals is that the holders of the applications have repeatedly failed to file required annual reports on these NDA's.